| Overview |
| bs-21011R-Cy3 |
| PAMCI/RASF9 Polyclonal Antibody, Cy3 Conjugated |
| IF(IHC-P), IF(IHC-F), IF(ICC) |
| Mouse |
| Human, Rat, Cow, Sheep, Rabbit |
| Specifications |
| Cy3 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human PAMCI/RASF9 |
| Polyclonal |
| #REF! |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 9182 |
| O75901 |
| Cytoplasm |
| P CIP1; P-CIP1; PAM COOH-terminal interactor protein 1; PCIP; Peptidylglycine alpha amidating monooxygenase COOH terminal interactor; peptidylglycine alpha-amidating monooxygenase COOH terminal interactor protein 1; Peptidylglycine alpha-amidating monooxygenase COOH-terminal interactor; Ras association (RalGDS/AF 6) domain family (N terminal) member 9; Ras association domain-containing protein 9; RASF9_HUMAN; Rassf9. |
| May play a role in regulating vesicuar trafficking in cells. |
| Application Dilution |
| IF(IHC-P) |
1:50-200 |
| IF(IHC-F) |
1:50-200 |
| IF(ICC) |
1:50-200 |